Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

An unusual case of thoracic empyema caused by Granulicatella elegans (nutritionally variant streptococci) in a patient with pulmonary tuberculosis and human immunodeficiency virus infection.

Mvelase NR, Marajh K, Hattingh O, Mlisana KP.

JMM Case Rep. 2016 Oct 27;3(5):e005058. doi: 10.1099/jmmcr.0.005058. eCollection 2016 Oct.

2.

Analysis of clinical and microbiological data on Acinetobacter baumannii strains assist the preauthorization of antibiotics at the patient level for an effective antibiotic stewardship program.

Swe Swe-Han K, Mlisana KP, Pillay M.

J Infect Public Health. 2017 Feb 22. pii: S1876-0341(17)30049-7. doi: 10.1016/j.jiph.2017.01.014. [Epub ahead of print]

3.

Antimicrobial stewardship in South Africa: a fruitful endeavour.

Ramsamy Y, Muckart DJ, Mlisana KP.

Lancet Infect Dis. 2016 Sep;16(9):982-3. doi: 10.1016/S1473-3099(16)30052-4. Epub 2016 Jun 14. No abstract available.

PMID:
27312578
4.

Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.

Desjardins CA, Cohen KA, Munsamy V, Abeel T, Maharaj K, Walker BJ, Shea TP, Almeida DV, Manson AL, Salazar A, Padayatchi N, O'Donnell MR, Mlisana KP, Wortman J, Birren BW, Grosset J, Earl AM, Pym AS.

Nat Genet. 2016 May;48(5):544-51. doi: 10.1038/ng.3548. Epub 2016 Apr 11.

5.

Empirical antimicrobial therapy for probable v. directed therapy for possible ventilator-associated pneumonia in critically injured patients.

Ramsamy Y, Muckart DJ, Bruce JL, Hardcastle TC, Han KS, Mlisana KP.

S Afr Med J. 2016 Jan 6;106(2):196-200. doi: 10.7196/SAMJ.2016.v106i2.9870.

PMID:
26821903
6.

Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.

Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Pym AS, Earl AM.

PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep.

7.

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.

Abdool Karim SS, Abdool Karim Q, Kharsany AB, Baxter C, Grobler AC, Werner L, Kashuba A, Mansoor LE, Samsunder N, Mindel A, Gengiah TN; CAPRISA 004 Trial Group.

N Engl J Med. 2015 Aug 6;373(6):530-9. doi: 10.1056/NEJMoa1410649.

8.

Novel imidazo[2,1-b]-1,3,4-thiadiazoles as promising antifungal agents against clinical isolate of Cryptococcus neoformans.

Alwan WS, Karpoormath R, Palkar MB, Patel HM, Rane RA, Shaikh MS, Kajee A, Mlisana KP.

Eur J Med Chem. 2015 May 5;95:514-25. doi: 10.1016/j.ejmech.2015.03.021. Epub 2015 Mar 12.

PMID:
25847769
9.

Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa.

Dlamini-Mvelase NR, Werner L, Phili R, Cele LP, Mlisana KP.

BMC Infect Dis. 2014 Aug 16;14:442. doi: 10.1186/1471-2334-14-442.

10.

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.

Karim QA, Kharsany AB, Frohlich JA, Baxter C, Yende N, Mansoor LE, Mlisana KP, Maarschalk S, Arulappan N, Grobler A, Sibeko S, Omar Z, Gengiah TN, Mlotshwa M, Samsunder N, Karim SS.

Trials. 2011 Mar 7;12:67. doi: 10.1186/1745-6215-12-67.

11.

Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial.

Karim QA, Kharsany AB, Naidoo K, Yende N, Gengiah T, Omar Z, Arulappan N, Mlisana KP, Luthuli LR, Karim SS.

Contemp Clin Trials. 2011 May;32(3):333-8. doi: 10.1016/j.cct.2011.01.005. Epub 2011 Jan 26.

12.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group.

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.

13.

Patients' readiness to start highly active antiretroviral treatment for HIV.

Gebrekristos HT, Mlisana KP, Karim QA.

BMJ. 2005 Oct 1;331(7519):772-5. No abstract available.

14.

Evolution of epidemiologic methods and concepts in selected textbooks of the 20th century.

Zhang FF, Michaels DC, Mathema B, Kauchali S, Chatterjee A, Ferris DC, James TM, Knight J, Dounel M, Tawfik HO, Frohlich JA, Kuang L, Hoskin EK, Veldman FJ, Baldi G, Mlisana KP, Mametja LD, Diaz A, Khan NL, Sternfels P, Sevigny JJ, Shamam A, Morabia A.

Soz Praventivmed. 2004;49(2):97-104.

PMID:
15150860
15.

Mycobacterium marinum hand infection.

Jones EJ, Mlisana KP, Peer AK.

Br J Plast Surg. 2001 Mar;54(2):181. No abstract available.

PMID:
11207141
16.

Hepatitis B infection in black children from residential care facilities in KwaZulu-Natal. Implications for adoption and foster care.

Solarsh GC, McKerrow N, Mlisana KP, Loening WE, Gouws E.

S Afr Med J. 1996 Apr;86(4):345-9.

PMID:
8693369
17.
18.

Syphilis in the 'unbooked' pregnant woman.

Mlisana KP, Monokoane S, Hoosen AA, Moodley J, Adhikari M, Taylor L.

S Afr Med J. 1992 Jul;82(1):18-20.

PMID:
1298218

Supplemental Content

Loading ...
Support Center